Novel staphylococcal inhibitors of neutrophil granule enzymes

K-REx Repository

Show simple item record Ploscariu, Nicoleta Teodora 2018-04-12T15:55:03Z 2018-04-12T15:55:03Z 2018-05-01 en_US
dc.description.abstract Neutrophils are our most abundant white blood cells and the first leukocytes to infiltrate sites of infection or damaged/healing tissue. Activation of neutrophils results in the mobilization of several types of granules stored within their cytosol, such as the so-called azurophilic granules, which either fuse with the maturing endophagocytic compartment or are released into the extracellular environment. One of the most abundant component of zurophilic granules is a heme-containing enzyme called myeloperoxidase (MPO), which reduces the H₂O₂ produced by the neutrophil’s respiratory burst to generate cytotoxic hypohalous acids, most typically HOCl. While neutrophil granule enzymes are essential for our innate defenses, neutrophil-driven inflammation outside this beneficial context lies at the heart of many non-infectious human diseases. Staphylococcus aureus and closely related species are highly adapted to their hosts and have evolved many strategies to resist opsonization and phagocytosis. S. aureus shows resistance to killing following uptake into the phagosome, which suggests that the bacterium can actively evade specific intracellular killing mechanisms used by neutrophils. Recent work found a highly conserved S. aureus protein, SPIN (for Staphylococcal Peroxidase INhibitor), that specifically binds and inhibits MPO [1]. This study was focused on characterizing the structure/function relationship for MPO inhibitors, SPIN proteins. To identify key residues for SPIN function in more detail, we examined two types of SPIN proteins using structural methods, direct binding assays, and functional assays for MPO activity: deletion mutants and SPIN proteins originating from divergent staphylococcal species. Together, these studies shed light on the molecular features which determine the specificity of SPIN proteins for MPO and suggest potential avenues for using this information toward the design of synthetic MPO inhibitors. In addition to the focus on targeted inhibition of MPO for its therapeutic value in treatment of a number of significant human inflammatory diseases, our investigations contributed in expanding our knowledge on infection spreading. As a first cellular host defense response, the neutrophil interaction with pathogens are of major interest. Characterization of staphylococcal immune evasion proteins is vital for understanding bacterial survival when encountering neutrophils and their bioactive constituents. en_US
dc.description.sponsorship US National Institutes of Health Grants AI111203 and GM121511 en_US
dc.language.iso en_US en_US
dc.publisher Kansas State University en
dc.subject Myeloperoxidase en_US
dc.subject Inhibitor
dc.subject Staphylococcus aureus
dc.subject Staphylococcus delphini
dc.subject Immune Evasion
dc.subject X-ray Crystallography
dc.title Novel staphylococcal inhibitors of neutrophil granule enzymes en_US
dc.type Dissertation en_US Doctor of Philosophy en_US
dc.description.level Doctoral en_US
dc.description.department Department of Biochemistry and Molecular Biophysics en_US
dc.description.advisor Brian V. Geisbrecht en_US 2018 en_US May en_US

Files in this item

This item appears in the following Collection(s)

Show simple item record

Search K-REx


My Account


Center for the

Advancement of Digital